(Sharecast News) - International healthcare group Alliance Pharma announced the postponement of its preliminary results for the year ended 31 December on Monday.
The AIM-traded firm said the results, initially scheduled for 23 April, would now be delayed until early May.
It said it expected to provide an update on the publication date by 26 April.
Following an earlier announcement on 5 April, Alliance Pharma informed shareholders that despite the advanced stage of the audit process, its auditor, Deloitte LLP, had requested more time to finalise their work.
"Alliance reiterates that the details provided in the full year trading update on 29 January remain accurate," the board said in its statement.
At 1414 BST, shares in Alliance Pharma were down 1.63% at 36.25p.
Reporting by Josh White for Sharecast.com.
Alliance Pharma (APH)